Clinical Trial Update: To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy after HIFU induction for early triple-negative breast cancer is ongoing, with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer, TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: UNKNOWN